Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Mimedx Group Inc (NASDAQ: MDXG) was $6.16 for the day, down -2.69% from the previous closing price of $6.33. In other words, the price has decreased by -$2.69 from its previous closing price. On the day, 0.54 million shares were traded. MDXG stock price reached its highest trading level at $6.39 during the session, while it also had its lowest trading level at $6.155.
Ratios:
Our analysis of MDXG’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.04 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 36.52. For the most recent quarter (mrq), Quick Ratio is recorded 3.11 and its Current Ratio is at 3.57. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on March 07, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On October 27, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $12.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $7.Mizuho initiated its Buy rating on October 13, 2022, with a $7 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 13 ’24 when Hulse William Frank IV sold 20,381 shares for $7.95 per share. The transaction valued at 162,029 led to the insider holds 479,959 shares of the business.
Whitlow Ricci S sold 15,271 shares of MDXG for $122,351 on Feb 20 ’24. The Chief Operating Officer now owns 401,050 shares after completing the transaction at $8.01 per share. On Feb 16 ’24, another insider, Whitlow Ricci S, who serves as the Chief Operating Officer of the company, sold 15,493 shares for $8.07 each. As a result, the insider received 125,075 and left with 416,321 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDXG now has a Market Capitalization of 905261248 and an Enterprise Value of 873808896. As of this moment, Mimedx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.89, and their Forward P/E ratio for the next fiscal year is 14.33. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.19. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.82 while its Price-to-Book (P/B) ratio in mrq is 6.31. Its current Enterprise Value per Revenue stands at 2.718 whereas that against EBITDA is 21.553.
Stock Price History:
Over the past 52 weeks, MDXG has reached a high of $9.27, while it has fallen to a 52-week low of $3.31. The 50-Day Moving Average of the stock is -20.04%, while the 200-Day Moving Average is calculated to be -18.34%.
Shares Statistics:
MDXG traded an average of 782.82K shares per day over the past three months and 656100 shares per day over the past ten days. A total of 146.23M shares are outstanding, with a floating share count of 112.98M. Insiders hold about 23.12% of the company’s shares, while institutions hold 41.76% stake in the company. Shares short for MDXG as of 1711584000 were 5175898 with a Short Ratio of 6.61, compared to 1709164800 on 5295181. Therefore, it implies a Short% of Shares Outstanding of 5175898 and a Short% of Float of 3.55.
Earnings Estimates
The current market rating for Mimedx Group Inc (MDXG) reflects the collective analysis of MDxHealth SA analysts closely monitoring its performance.The consensus estimate for the next quarter is $6.16, with high estimates of $81.23 and low estimates of $1.47.
EPS for the following year is $Stocks, with Stocks analysts recommending between $ETF and $Stocks.
